CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 813 enrolled
Drug / intervention
Third trimester ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05787054
NCT05787054N/ACompleted
CompareCT.gov

Single Scan Screening of Fetal Growth Restriction Versus Longitudinal Scan Screening in the Third Trimester: a Multicenter Randomized Protocol

Fondazione Policlinico Universitario Agostino Gemelli IRCCS·interventional·Posted Mar 28, 2023·Updated Apr 30, 2025

In Brief

A clinical study evaluating Third trimester ultrasound for Fetal Growth Retardation and Fetal; Slow Growth. Completed, enrolled 813 participants across 1 site.

Detailed Summary

The aim of this trial is to assess the efficacy of two screening protocols for the detection of fetal growth disorders. In Italy at the moment the screening protocol should not be universal but only on clinical indications. In some Regions the screening is offered to every pregnant women with an early third trimester scan at 28-32 weeks'gestation or, in other Regions, according to the new national recommandations, a growth scan during the third trimester is provided only if there is a clinical indication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFetal Growth Retardation, Fetal; Slow Growth
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 28, 2023
Enrollment StartJan 1, 2021
Primary CompletionMar 1, 2023
Study CompletionMay 27, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 3.3 years ago

Interventions

Third trimester ultrasoundother

Single scan versus Longitudinal scan